Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?

M. Gabriela Cabanilla; Bassam Ghanem; Boris Jegorović; Todd C. Lee; Elias B. Chahine; Daniel T. Anderson; Nardine Karam Salgado; Joshua Eudy; Harjot K. Singh; Ahmed A. Muyidi; Roberta Astorri; Alberto E. Maraolo; Ana Cristina Antolí Royo; Alfredo J. Mena Lora; Bernardo V. Pimentel; Brad Spellberg

Article

Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?

European Journal of Hospital Pharmacy

DOI: 10.1136/ejhpharm-2026-005095

0Citations

1Readers

Get full text

Author supplied keywords

Cite

CITATION STYLE

APA

Cabanilla, M. G., Ghanem, B., Jegorović, B., Lee, T. C., Chahine, E. B., Anderson, D. T., … Spellberg, B. (2026). Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach? European Journal of Hospital Pharmacy. BMJ Publishing Group. https://doi.org/10.1136/ejhpharm-2026-005095

Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?

Author supplied keywords

Cite

Register to see more suggestions